All Stories

  1. PNPLA3 I148M by disrupting PPAR gamma signaling regulates aquaporin 3 in stellate cells

    Article • Scientific Reports, November 2017, Nature

    thierry claudel, PhD Francesca Virginia Bruschi

  2. how PNPLA3 polymorphism impacts on liver homeostasis

    Article • Hepatic Medicine Evidence and Research, November 2017, Dove Medical Press

    PhD Francesca Virginia Bruschi, thierry claudel

  3. FXR activated by bile acids controls CHOP

    Article • FEBS Letters, October 2017, Wiley

    thierry claudel

  4. adiponectin by regulating PPAR alpha activity regulates aquaporin 3 in HSC

    Article • Biochemical and Biophysical Research Communications, August 2017, Elsevier

    thierry claudel, PhD Francesca Virginia Bruschi

  5. heme degradation products accumulates in septic patients and affects their liver functions

    Article • Journal of Hepatology, August 2017, Elsevier

    thierry claudel

  6. PNPLA3 mutant lowers PPARg signaling in HSC

    Article • Hepatology, April 2017, Wiley

    PhD Francesca Virginia Bruschi, thierry claudel, Fabio Marra

  7. ABC transporters and their role in liver disease

    Article • February 2017, Wiley

    thierry claudel

  8. description of NorUDCA therapeutic interest

    Article • Digestive Diseases, January 2017, Karger Publishers

    thierry claudel

  9. role of BSEP in cholestasis

    Article • Gastroenterology, April 2016, Elsevier

    thierry claudel

  10. PAK1 deactivates intestinal PPAR gamma and thus promote inflammation

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, October 2015, Elsevier

    thierry claudel

  11. book chapter for students learning about bile acids signaling

    Article • August 2015, Wiley

    thierry claudel

  12. PAK1 and PPAR gamma modulate intestinal inflammation

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    thierry claudel

  13. UDCA antagonizes FXR signaling in obese patients

    Article • Journal of Hepatology, June 2015, Elsevier

    thierry claudel

  14. NorUDCA in liver disease

    Article • Digestive Diseases, May 2015, Karger Publishers

    thierry claudel

  15. miR-124a regulates ATGL and CGI58

    Article • International Journal of Molecular Sciences, April 2015, MDPI AG

    thierry claudel

  16. NorUDCA improves schistosomiasis

    Article • Journal of Hepatology, April 2015, Elsevier

    thierry claudel

  17. growth hormone deficiency increases liver fibrosis

    Article • Hepatology, January 2015, Wiley

    thierry claudel

  18. adipocyte physiology influences liver disease in humans

    Article • Metabolism, December 2014, Elsevier

    thierry claudel

  19. role of lipids in fatty liver development

    Article • Trends in Endocrinology and Metabolism, November 2014, Elsevier

    thierry claudel

  20. arachidonic acid controls cholesterol elimination via BSEP

    Article • Cell Metabolism, November 2014, Elsevier

    thierry claudel

  21. GH and liver fibrosis

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    thierry claudel

  22. role of ATGL in adipose tissue in a NASH model

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, July 2014, Elsevier

    thierry claudel

  23. BSEP KO as a model for NASH

    Article • Gastroenterology, May 2014, Elsevier

    thierry claudel

  24. role of statin in PBC treatment

    Article • Liver International, February 2014, Wiley

    thierry claudel

  25. ATGL protects the liver from inflammation by PPAR alpha activation

    Article • Hepatology, January 2014, Wolters Kluwer Health

    thierry claudel

  26. bile acids signaling in fatty liver disease

    Article • Seminars in Liver Disease, November 2013, Thieme Publishing Group

    thierry claudel

  27. fenofibrate can suppress B cell lymphoma

    Article • Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, October 2013, Elsevier

    thierry claudel

  28. an editorial summarizing the relation between adiponectin microbiome and bile acid signaling

    Article • Hepatology, June 2013, Wiley

    thierry claudel

  29. FXR regulates CETP

    Article • Journal of Lipid Research, April 2013, American Society for Biochemistry & Molecular Biology (ASBMB)

    thierry claudel, Professor Pancras C.W. Hogendoorn

  30. overview of bile signaling in liver physio and pathophysiology

    Article • Journal of Hepatology, January 2013, Elsevier

    thierry claudel

  31. niacin regulates liver apoA in humans

    Article • Journal of Lipid Research, August 2012, American Society for Biochemistry & Molecular Biology (ASBMB)

    thierry claudel

  32. ATGL deficiency protects from liver ER stress

    Article • Hepatology, May 2012, Wiley

    thierry claudel

  33. FGF19 reduces hepatic apoA expression

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2012, Wolters Kluwer Health

    thierry claudel

  34. co activation of FXR and TGR5 ameliortaes cholangiopathy via FXR

    Article • Hepatology, September 2011, Wolters Kluwer Health

    Professor Mario Strazzabosco, thierry claudel

  35. FXR represses liver apoA directly

    Article • Journal of Clinical Investigation, September 2011, American Society for Clinical Investigation

    thierry claudel

  36. bile acids activated nuclear receptors in physiology

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, August 2011, Elsevier

    thierry claudel

  37. PPAR alpha activity is controlled by the release of fatty acids depending on DBP

    Article • Proceedings of the National Academy of Sciences, March 2011, Proceedings of the National Academy of Sciences

    thierry claudel

  38. overview of bile acid receptors and disease in 2011

    Article • Digestive Diseases, January 2011, Karger Publishers

    thierry claudel

  39. curcumin ameliorates cholangiopathy

    Article • Gut, March 2010, BMJ

    thierry claudel

  40. statin reduces dyslipidemia and ameliorates vascular functions in PBC

    Article • Atherosclerosis, March 2010, Elsevier

    thierry claudel

  41. overview of animal models useful for cholangiopathies

    Article • Digestive Diseases, January 2010, Karger Publishers

    thierry claudel

  42. overview of the year 2010 of bile acid signaling

    Article • Digestive Diseases, January 2010, Karger Publishers

    thierry claudel

  43. high plasmatic bile acids do not increase energy expenditure

    Article • Nutrition & Metabolism, January 2010, Springer Science + Business Media

    thierry claudel

  44. book chapter for students learning about bile acids signaling

    Article • October 2009, Springer Science + Business Media

    thierry claudel

  45. rev-erb alpha controls liver lipid and bile homeostasis

    Article • PLoS Biology, September 2009, PLOS

    thierry claudel

  46. phospholipid homeostasis in ABCB4 deficiency

    Article • Liver International, April 2008, Wiley

    thierry claudel

  47. review about metabolism connection and clock

    Article • FEBS Letters, April 2007, Wiley

    thierry claudel

  48. FXR regulates glucose and lipid metabolism

    Article • Arteriosclerosis Thrombosis and Vascular Biology, October 2005, Wolters Kluwer Health

    thierry claudel

  49. review about FXR and metabolism

    Article • Reviews in Endocrine and Metabolic Disorders, December 2004, Springer Science + Business Media

    thierry claudel

  50. review about FXR in early years

    Article • Expert Opinion on Investigational Drugs, September 2004, Informa Healthcare

    thierry claudel

  51. FXR induces VLDL receptor expression in hepatocytes

    Article • FEBS Letters, April 2004, Wiley

    thierry claudel

  52. FXR repress apoC3 expression

    Article • Gastroenterology, August 2003, Elsevier

    thierry claudel

  53. FXR induces UGT2B4 and controls bile acids toxicity

    Article • Gastroenterology, June 2003, Elsevier

    thierry claudel

  54. FXR regulates PPAR alpha

    Article • Molecular Endocrinology, February 2003, Endocrine Society

    thierry claudel

  55. FXR and bile acids lower apoA1 and HDL

    Article • Journal of Clinical Investigation, April 2002, American Society for Clinical Investigation

    thierry claudel

  56. FXR represses apopA1 and thus HDL levels

    Article • Journal of Clinical Investigation, April 2002, American Society for Clinical Investigation

    thierry claudel

  57. RXR activation reduced atherosclerosis

    Article • Proceedings of the National Academy of Sciences, February 2001, Proceedings of the National Academy of Sciences

    thierry claudel

  58. a book chapter with the basics about bile acids signaling

    Article • De Gruyter

    thierry claudel